scholarly journals Pediatric Parapneumonic Effusion/Pleural Empyema in Japan

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Tadashi Hoshino ◽  
Daisuke Nishima ◽  
Mayumi Enseki ◽  
Naoki Umehara ◽  
Chie Fukasawa ◽  
...  
Keyword(s):  
Pleural Empyema ◽  
Parapneumonic Effusion

Change in Bacterial Causes of Community-Acquired Parapneumonic Effusion and Pleural Empyema in Children 6 Years After 13-Valent Pneumococcal Conjugate Vaccine Implementation

2018 ◽  
Vol 8 (5) ◽  
pp. 474-477 ◽  
Author(s):  
Fouad Madhi ◽  
Corinne Levy ◽  
Laurence Morin ◽  
Philippe Minodier ◽  
François Dubos ◽  
...  
Keyword(s):  
Conjugate Vaccine ◽  
Pneumococcal Conjugate Vaccine ◽  
Group A Streptococcus ◽  
Pneumococcal Infection ◽  
Pleural Empyema ◽  
Parapneumonic Effusion ◽  
Before And After ◽  
Group A

AbstractWe describe here changes in the bacterial causes of pleural empyema before and after implementation of the 13-valent pneumococcal conjugate vaccine (PCV13) program in France (2009–2017). For 220 (39.3%) of 560 children, a bacterial cause was found. The frequency of pneumococcal infection decreased during the study from 79.1% in 2009 to 36.4% in 2017 (P < .001). Group A streptococcus is now the leading cause of documented empyema (45.5%).

scholarly journals Pleural Tap-Guided Antimicrobial Treatment for Pneumonia with Parapneumonic Effusion or Pleural Empyema in Children: A Single-Center Cohort Study

2019 ◽  
Vol 8 (5) ◽  
pp. 698 ◽  
Author(s):  
Patrick M. Meyer Sauteur ◽  
Ariane Burkhard ◽  
Ueli Moehrlen ◽  
Christa Relly ◽  
Christian Kellenberger ◽  
...  
Keyword(s):  
Day Treatment ◽  
Pleural Empyema ◽  
Community Acquired Pneumonia ◽  
Antimicrobial Treatment ◽  
Full Recovery ◽  
Parapneumonic Effusion ◽  
Polymerase Chain ◽  
Management Approaches ◽  
Antigen Testing

Parapneumonic effusion or pleural empyema (PPE/PE) is a frequent complication of community-acquired pneumonia (CAP) in children. Different management approaches exist for this condition. We evaluated a 14-day treatment with amoxicillin (AMX) with/without clavulanic acid (AMC) confirmed or modified by microbiological findings from pleural tap. Children ≤16 years of age with radiologically diagnosed PPE/PE and initial diagnostic pleural tap were included at University Children’s Hospital Zurich from 2001–2015. AMX/AMC was given for 14 days and rationalized according to microbiological pleural tap results. Clinical and radiological follow-up was scheduled until six months or full recovery. In 114 of 147 (78%) children with PPE/PE a pathogen was identified by culture, polymerase chain reaction (PCR), and/or antigen testing. Streptococcus pneumoniae was detected in 90 (79%), S. pyogenes in 13 (11%), and Staphylococcus aureus in seven cases (6%), all but two cultured pathogens (96%) were sensitive to AMX/AMC. One-hundred two of 147 (69%) patients received treatment with AMX/AMC for 14 days. They recovered more rapidly than patients with a different management (p = 0.026). Of 139 children with follow-up, 134 (96%) patients fully recovered. In conclusion, 14-day AMX/AMC treatment confirmed and rarely modified by microbiological findings from pleural tap resulted in full recovery in >95% of children with PPE/PE.

Diagnosis of pleural empyema/parapneumonic effusion by next-generation sequencing

2021 ◽  
pp. 1-10
Author(s):  
Yoshiki Shiraishi ◽  
Kirill Kryukov ◽  
Katsuyoshi Tomomatsu ◽  
Fumio Sakamaki ◽  
Shigeaki Inoue ◽  
...  
Keyword(s):  
Next Generation Sequencing ◽  
Pleural Empyema ◽  
Parapneumonic Effusion ◽  
Next Generation ◽  
Generation Sequencing

scholarly journals Videothoracoscopy in Pleural Empyema Following Methicillin-ResistantStaphylococcus aureus(MRSA) Lung Infection

2009 ◽  
Vol 9 ◽  
pp. 723-728 ◽  
Author(s):  
Duilio Divisi ◽  
Giovanna Imbriglio ◽  
Roberto Crisci
Keyword(s):  
Carbon Dioxide ◽  
Pleural Effusion ◽  
Complete Resolution ◽  
Pleural Cavity ◽  
Pleural Empyema ◽  
Lung Infection ◽  
Cardiac Insufficiency ◽  
Parapneumonic Effusion ◽  
Thoracostomy Tube ◽  
Therapeutic Procedures

Our study shows the different therapeutic procedures in 64 patients with pleural effusion due to MRSA pneumonia. The thoracostomy tube associated with pleural washing was decisive in 10 simple effusion patients. Video-assisted thoracic surgery allowed a complete resolution of the disease in 22 complex parapneumonic effusion patients. In 20 of 32 patients with frank pus in the pleural cavity, the videothoracoscopic insufflation of carbon dioxide (CO2) before thoracotomy facilitated the dissection of the lung tissue. In 12 patients, this approach was not applied because of cardiac insufficiency. Videothoracoscopy and decortication after thoracotomy ensured the recovery of functions.

scholarly journals Etiology of parapneumonic effusion and pleural empyema in children. The role of conventional and molecular microbiological tests.

2016 ◽  
Vol 116 ◽  
pp. 28-33 ◽  
Author(s):  
Katarzyna Krenke ◽  
Ewa Sadowy ◽  
Edyta Podsiadły ◽  
Waleria Hryniewicz ◽  
Urszula Demkow ◽  
...  
Keyword(s):  
Pleural Empyema ◽  
Parapneumonic Effusion

scholarly journals Surgical Treatment of Pleural Empyema – Our Results

PRILOZI ◽  
2017 ◽  
Vol 38 (2) ◽  
pp. 99-105
Author(s):  
Goran Kondov ◽  
Zoran Spirovski ◽  
Irena Kondova-Topuzovska ◽  
Anita Kokareva ◽  
Risto Colanceski ◽  
...  
Keyword(s):  
Surgical Treatment ◽  
Minimally Invasive ◽  
Thoracic Surgery ◽  
Early Recognition ◽  
Pleural Empyema ◽  
Parapneumonic Effusion ◽  
Pleural Drainage ◽  
Adequate Treatment ◽  
Advanced Stages ◽  
The Mean

Abstract Pleural infection is a frequent clinical condition. Prompt treatment has been shown to reduce morbidity, mortality and duration of hospital stay. Unfortunately, advanced stages of empyema need to use extensive surgery - decortications or thoracoplasty. Early recognition of the parapneumonic effusion and the adequate treatment with thoracentesis or pleural drainage, which is minimally invasive, is possible not to prograde the process and not to become empyema. Aim: To analyze the results of the surgical treatment in patients with empyema treated at Clinic for thoracic surgery. Material and methods: In the retrospective study we analyzed 234 patients with empyema which were treated at the Clinic for Thoracic Surgery in 5 year period (2011-2015). The mean age of the patients was 51.94 years. They were treated with pleural drainage, decortications or thoracoplasty. Results: With pleural drainage were treated 165/234 (70.51%) patients, of which successfully were finished 124/165 (75.15%), but 41/165 (24.85%) were indicated after the decortications. A total of 108/234 (46.15%) were treated with decortications from which, primary decortications were indicated in 67/234 (28.63%) patients. 5/234 (2.14%) patients were treated with thoracoplasty – 3 of the patients with decortications and 2 with primary indicated thoracoplasty according to the local findings, long term untreated empyema and bad general condition. The Mean hospitalization was 17.4 days, of which 13.4 days after surgery. In the group with primary drainage it was detected a lethal outcome in 7/124 (5.64%) patients, 5/105 (4.76%) in the group with decortications and 2/5 (40%) in the group with thoracoplasty. Conclusion: Early detection of the parapneumonic effusion and the adequate treatment will prevent the appearance of empyema. If the empyema is detected it is necessary as early as possible to start the treatment with minimally invasive pleural drainage. In earlier stages it is possible to use less invasive decortications, using VATS than the open thoracotomy decortication which is more extensive surgical intervention.

Sign in / Sign up

Export Citation Format

Share Document